Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UARK 98-018, A Randomized Phase II Trial of DCEP or DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse in Patients With Multiple Myeloma

NCT00083681 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT00083681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00083681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UARK 98-018, A Randomized Phase II Trial of DCEP or DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse in Patients With Multiple Myeloma
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Completed
Start date
June 30, 1998
Completion date
May 31, 2005
Enrollment
180
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma